PulMedics, Inc. to Present at Medtech Insight's ''Investment in Innovation'' Conference.

IRVINE, Calif. -- PulMedics, Inc. has announced that it will be presenting at 11:00 A.M. this Thursday, February 10th at Medtech Insight's Prestigious "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" Conference, taking place February 10-11, 2005 at the Hyatt Regency Irvine in Irvine, California.

The company plans to premiere its integrated suite of metabolic products known as "The Metabolic Solution." These products are designed to address pandemic problem of obesity.

"Until now, there hasn't been an effective way to really know why a diet is working or failing. By trending certain metabolically-oriented parameters, our technology promises to provide much needed insight into whether the diet is to blame, or rather, whether the patient that has failed to adhere to the diet," said PulMedics C.E.O. and co-founder Craig Flanagan Ph.D. "PulMedics has patented a unique system called the 'Metabolic Solution.' This system uses sophisticated sensor-based technologies to measure a number of metabolically-oriented clinical indices with a five-minute breath test. These indices provide the clinician with a roadmap for creating and effectively managing personalized weight management strategies."

Flanagan continued: "Now a person can have a customized weight loss strategy developed around their unique metabolic characteristics. We believe that individuals and clinicians are tired of weight loss strategies that promise and don't deliver. Our 'Metabolic Solution' technologies, the CalorieMeter and MetaboLab employ a science-based approach to weight management known as Indirect Calorimetry. Indirect Calorimetry uses a pain-free breath test to precisely measure an individual's unique metabolic characteristics. This information is then trended and used to guide in the development of an individually tailored weight management program."

PulMedics believes that the diagnostic and prescriptive value in trending these indices will make the Metabolic Solution an invaluable tool for clinicians, and that weekly patient assessment will become routine practice for a variety of weight management programs.

PulMedics is a privately held company located in Salt Lake City, Utah. Technologies developed, and under development, offer the first affordable and accurate techniques for determination of human metabolic rate, body mass, respiratory quotient and percentage body fat. For additional information about PulMedics Inc, please visit www.PulMedics.com.

MedTech Insight, "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies", is a leading technology conference wherein emerging companies present ideas and solutions to modern medical challenges. The two-day event offers innovators seeking strategic partners and/or investment an opportunity to present to approximately 400 senior executives representing major medical technology companies and investment firms.

Now a division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. To register for In3 Irvine or for more information on Medtech Insight, please call Scott Pantel at 949-219-0150 or 888-290-2225 toll-free in the U.S., e-mail [e-mail], or visit www.medtechinsight.com.